Analysts’ Weekly Ratings Updates for CME Group (CME)

Several analysts have recently updated their ratings and price targets for CME Group (NASDAQ: CME):

• 4/9/2024 – CME Group had its price target raised by analysts at Morgan Stanley from $222.00 to $225.00. They now have an “equal weight” rating on the stock.
• 4/8/2024 – CME Group had its price target raised by analysts at Barclays PLC from $225.00 to $226.00. They now have an “equal weight” rating on the stock.
• 4/5/2024 – CME Group had its “hold” rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They now have a $210.00 price target on the stock, down previously from $235.00.
• 4/3/2024 – CME Group had its “market perform” rating reaffirmed by analysts at Keefe, Bruyette & Woods. They now have a $229.00 price target on the stock.
• 3/6/2024 – CME Group had its price target raised by analysts at Argus from $225.00 to $245.00. They now have a “buy” rating on the stock.
• 2/15/2024 – CME Group had its price target raised by analysts at Barclays PLC from $222.00 to $225.00. They now have an “equal weight” rating on the stock.

CME Group Price Performance

Shares of NASDAQ:CME traded up $0.77 during trading on Thursday, reaching $212.77. 1,653,373 shares of the company traded hands, compared to its average volume of 1,780,624. The company’s 50 day moving average is $213.79 and its two-hundred day moving average is $211.34. The firm has a market capitalization of $76.60 billion, a PE ratio of 23.99, a PEG ratio of 4.83 and a beta of 0.49. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $175.73 and a 52 week high of $223.80.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.10. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same period last year, the business posted $1.92 EPS. The business’s revenue was up 19.2% compared to the same quarter last year. As a group, sell-side analysts predict that CME Group Inc. will post 9.6 earnings per share for the current year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Investors of record on Friday, March 8th were given a dividend of $1.15 per share. This is a boost from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date was Thursday, March 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.16%. CME Group’s payout ratio is presently 51.86%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of CME. Vanguard Group Inc. raised its stake in shares of CME Group by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock valued at $7,044,821,000 after purchasing an additional 215,044 shares during the period. Capital World Investors raised its stake in shares of CME Group by 8.7% during the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after purchasing an additional 1,172,575 shares during the period. Capital International Investors raised its stake in shares of CME Group by 0.4% during the 4th quarter. Capital International Investors now owns 12,739,369 shares of the financial services provider’s stock valued at $2,683,012,000 after purchasing an additional 50,626 shares during the period. Geode Capital Management LLC raised its stake in shares of CME Group by 1.6% during the 1st quarter. Geode Capital Management LLC now owns 7,085,300 shares of the financial services provider’s stock valued at $1,355,370,000 after purchasing an additional 108,740 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in shares of CME Group by 0.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 6,913,562 shares of the financial services provider’s stock valued at $1,224,597,000 after purchasing an additional 31,354 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.